CLINICAL TRIALS PROFILE FOR AMINOPHYLLINE
✉ Email this page to a colleague
All Clinical Trials for aminophylline
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00130598 ↗ | PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION | Completed | Swiss National Science Foundation | Phase 2/Phase 3 | 2005-06-01 | Contrast nephropathy (CN) remains a common complication of radiographic procedures and an important cause of hospital-acquired acute renal failure. Only hydration with saline is uniformly accepted and used in clinical practice as a cornerstone for the prevention of CN. But the optimal preventive strategy for CN is not known. Sodium bicarbonate might be even more effective than hydration with sodium chloride for prophylaxis of CN. Therefore the aim of the study is to evaluate the efficacy of two regimens of sodium bicarbonate compared with a prolonged infusion of sodium chloride in the prevention of CN. Primary endpoint: Decrease in glomerular filtration rate (GFR) within 48 hours. |
| NCT00130598 ↗ | PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION | Completed | University Hospital, Basel, Switzerland | Phase 2/Phase 3 | 2005-06-01 | Contrast nephropathy (CN) remains a common complication of radiographic procedures and an important cause of hospital-acquired acute renal failure. Only hydration with saline is uniformly accepted and used in clinical practice as a cornerstone for the prevention of CN. But the optimal preventive strategy for CN is not known. Sodium bicarbonate might be even more effective than hydration with sodium chloride for prophylaxis of CN. Therefore the aim of the study is to evaluate the efficacy of two regimens of sodium bicarbonate compared with a prolonged infusion of sodium chloride in the prevention of CN. Primary endpoint: Decrease in glomerular filtration rate (GFR) within 48 hours. |
| NCT00312273 ↗ | Aminophylline in Bradyasystolic Cardiac Arrest | Completed | Heart and Stroke Foundation of Canada | Phase 2 | 2001-01-01 | The purpose of this study is to evaluate the effect of aminophylline in patients with out-of-hospital bradyasystolic cardiac arrest. |
| NCT00312273 ↗ | Aminophylline in Bradyasystolic Cardiac Arrest | Completed | Vancouver Coastal Health Research Institute | Phase 2 | 2001-01-01 | The purpose of this study is to evaluate the effect of aminophylline in patients with out-of-hospital bradyasystolic cardiac arrest. |
| NCT00312273 ↗ | Aminophylline in Bradyasystolic Cardiac Arrest | Completed | Vancouver General Hospital | Phase 2 | 2001-01-01 | The purpose of this study is to evaluate the effect of aminophylline in patients with out-of-hospital bradyasystolic cardiac arrest. |
| NCT00442338 ↗ | Study of MK-0476 in Adult Patients With Acute Asthma (0476-334) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2007-03-01 | The study estimates the efficacy and safety of MK0476 and aminophylline intravenous administration in adult participants with acute asthma. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for aminophylline
Condition Name
Clinical Trial Locations for aminophylline
Trials by Country
Clinical Trial Progress for aminophylline
Clinical Trial Phase
Clinical Trial Sponsors for aminophylline
Sponsor Name
